It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 5.8% over the past month. However, a closer look at its sound financials ...

Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. The company reported strong earnings in the second quarter of 2025. It posted revenue ...

IXJ offers global healthcare exposure, capturing demographic shifts and innovation trends beyond U.S.-centric ETFs. Read why ...

You should have around $100 or so remaining from your initial $350 after buying one share each of AbbVie and Dominion Energy.

Wednesday, July 23, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Every investor in Abbott Laboratories (NYSE:ABT) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are institutions with 80% ownership. In ...

When torn between Envista (NVST) and Abbott (ABT) for the best value stock, one shines brighter. Envista flaunts a more appealing forward P/E ratio of 18.81 compared to Abbott's 24.16. Not just the ...

While Abbott Laboratories' stock dips by 5.5% over the past month, a closer look reveals robust fundamentals hinting at ...

Dividend growth rates over a 5-year or longer period can be a good indicator of strong growth potential in picking a stock ...

In two years, BrightSpire Capital (BRSP) will be growing its dividend and seeing strong performance. Read the full analysis ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.